Delivering world class medical care
Arogya Pharma partners with global pharmaceutical companies to provide reliable Contract Development and Manufacturing (CDMO) solutions. From early formulation to large-scale commercial production, we ensure quality, compliance, and scalability for sterile injectables, biologics, and complex generics.
It is a global Contract Development and Manufacturing Organization (CDMO) specializing in sterile injectables, complex generics, and biologics. Leveraging India’s cost-effective and high-quality production ecosystem, we support pharmaceutical companies worldwide with scalable, reliable, and compliant solutions
Frequently asked questions
We’ve put together answers to some of the most common questions about our Contract Development and Manufacturing (CDMO) services. If you don’t find what you’re looking for, feel free to contact our team directly.
- End-to-End Services.
- Regulatory Excellence
- Sterile Manufacturing
- Scalable Production
- Global Reach
- Innovation Focus
- Quality First
- Flexible Production
- Advanced R&D Facilities and State-of-the-Art Manufacturing
We provide end-to-end solutions including formulation development, clinical trial support, commercial manufacturing, regulatory guidance, and global supply chain management.
Yes. Our facilities are FDA, WHO, and GMP-certified, ensuring global compliance and the highest quality manufacturing standards..
Absolutely. Our infrastructure is designed to handle pilot batches, niche products, and high-volume commercial supply with equal efficiency.